Bide Pharmatech Co Ltd
SSE:688073
Bide Pharmatech Co Ltd
Bide Pharmatech Co., Ltd. engages in research and development of drugs. The company is headquartered in Shanghai, Shanghai and currently employs 617 full-time employees. The company went IPO on 2022-10-11. The firm's main businesses are the research, development, design, production and sales of drug molecular building blocks. The firm's main products are pharmaceutical molecular building blocks and scientific reagents. The firm's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The firm conducts business in Asia Pacific, India, Europe, the United States and other regions.
Bide Pharmatech Co., Ltd. engages in research and development of drugs. The company is headquartered in Shanghai, Shanghai and currently employs 617 full-time employees. The company went IPO on 2022-10-11. The firm's main businesses are the research, development, design, production and sales of drug molecular building blocks. The firm's main products are pharmaceutical molecular building blocks and scientific reagents. The firm's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The firm conducts business in Asia Pacific, India, Europe, the United States and other regions.
